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Résumé en
anglais
Obesity and being overweight are linked with a cluster of metabolic and vascular
disorders that have been termed the metabolic syndrome. This syndrome promotes
the incidence of cardiovascular diseases that are an important public health
problem because they represent a major cause of death worldwide. Whereas there
is not a universally-accepted set of diagnostic criteria, most expert groups agree
that this syndrome is defined by an endothelial dysfunction, an impaired insulin
sensitivity and hyperglycemia, dyslipidemia, abdominal obesity and hypertension.
Epidemiological studies suggest that the beneficial cardiovascular health effects of
diets rich in green tea are, in part, mediated by their flavonoid content, with
particular benefits provided by members of this family such as epigallocatechin
gallate (EGCG). Although their bioavailability is discussed, various studies suggest
that EGCG modulates cellular and molecular mechanisms of various symptoms
leading to metabolic syndrome. Therefore, according to in vitro and in vivo model
data, this review attempts to increase our understanding about the beneficial
properties of EGCG to prevent metabolic syndrome.
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